Facts
- HQ
- United States
- Sectors
- Higher Education
- Founded
- 1876
Is this your organization? Claim it
Fred Hutch-Led Synthesize Bio Raises $10M to Accelerate Drug Discovery Using AI Gene Expression Model
Seattle-based Synthesize Bio, led by Fred Hutchinson Cancer Center researchers, raised $10 million from Madrona to accelerate drug discovery using their AI model GEM-1, which predicts gene expression outcomes with lab-level accuracy. The startup aims to reduce drug development time and costs by simulating hypothetical lab experiments with generative genomics.
GeekWire Awards Health Innovation Finalists Spotlight Cancer-Fighting Biotechs Including Archon Biosciences with $20M AI-Driven Protein Therapy
The GeekWire Awards finalists for Health Innovation of the Year primarily consist of companies developing advanced cancer-fighting technologies, alongside startups improving healthcare management. Notable finalists include Archon Biosciences, which recently secured $20 million to develop AI-optimized protein therapies, Fred Hutch Cancer Center, and others.
Seattle-Area Longevity Biomedical to Go Public via SPAC in Q2 2023, Raising $30M with $236M Valuation
Longevity Biomedical, formed by merging Seattle-area startups Cerevast Medical, NovoKera, and Aegeria Soft Tissue, plans to go public via a SPAC merger expected to close in Q2 2023, raising at least $30 million. The combined company targets healthspan extension with treatments for stroke, blindness, and soft-tissue reconstruction, and is valued at $236.2 million.
